Atria Investments’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
BFS
II
OFS
PFG
PAW
UCFA
Atria Investments's IBD Position: Q2 2026 in Review
Atria Investments reduced its Inspire Corporate Bond ETF (IBD) stake by 5.1% in Q2 2026, selling an estimated $17.9K and leaving 13,959 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.
Atria Investments first reported a position in IBD in Q3 2018 and has held it in 20 quarters since. The position peaked at $34.1M in Q3 2024. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.
- Atria Investments held 13,959 shares of Inspire Corporate Bond ETF worth $332K as of Q2 2026.
- Atria Investments sold 752 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $17.9K.
- Inspire Corporate Bond ETF made up ﹤0.01% of Atria Investments's portfolio in Q2 2026, its #1787 holding.
- Atria Investments first reported a position in Inspire Corporate Bond ETF in Q3 2018 and has held it in 20 quarters since.
- Atria Investments's Inspire Corporate Bond ETF position peaked at $34.1M in Q3 2024.
- 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.
Based on Atria Investments's 13F filing for Q2 2026, filed 28 Jul 2026.